FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.350
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST - Market open
FibroGen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 180.02 | 147.75 | 140.73 | 235.31 | 176.32 | 256.58 | Upgrade
|
| Revenue Growth (YoY) | 16.15% | 4.99% | -40.19% | 33.46% | -31.28% | 20.48% | Upgrade
|
| Cost of Revenue | 219.81 | 309.34 | 299.95 | 449.19 | 260.64 | 210.41 | Upgrade
|
| Gross Profit | -39.79 | -161.59 | -159.21 | -213.88 | -84.32 | 46.17 | Upgrade
|
| Selling, General & Admin | 103.88 | 132.26 | 141.81 | 134.65 | 107.56 | 135.48 | Upgrade
|
| Operating Expenses | 103.88 | 132.26 | 141.81 | 134.65 | 107.56 | 135.48 | Upgrade
|
| Operating Income | -143.67 | -293.85 | -301.03 | -348.53 | -191.88 | -89.31 | Upgrade
|
| Interest Expense | -19.84 | -15.53 | -1.44 | -1.08 | -2.4 | -2.88 | Upgrade
|
| Interest & Investment Income | 7.59 | 10.75 | 7.6 | - | 5.81 | 15.46 | Upgrade
|
| Earnings From Equity Investments | 3.28 | 2.64 | 1.57 | 1.01 | -0.2 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -1.08 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -152.65 | -295.99 | -293.29 | -349.68 | -188.67 | -76.73 | Upgrade
|
| Merger & Restructuring Charges | -18.55 | -12.61 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -0.27 | -0.01 | - | -0.26 | 0.09 | Upgrade
|
| Pretax Income | -121.93 | -284.23 | -293.3 | -289.68 | -188.93 | -76.64 | Upgrade
|
| Income Tax Expense | -0.14 | 0 | 0.36 | 0.35 | 0.36 | 0.33 | Upgrade
|
| Net Income | -121.79 | -284.23 | -293.65 | -290.02 | -189.29 | -76.97 | Upgrade
|
| Net Income to Common | -121.79 | -284.23 | -293.65 | -290.02 | -189.29 | -76.97 | Upgrade
|
| Shares Outstanding (Basic) | 99 | 97 | 94 | 92 | 90 | 87 | Upgrade
|
| Shares Outstanding (Diluted) | 99 | 97 | 94 | 92 | 90 | 87 | Upgrade
|
| Shares Change (YoY) | 3.41% | 3.98% | 1.34% | 2.78% | 3.72% | 3.06% | Upgrade
|
| EPS (Basic) | -1.22 | -2.92 | -3.14 | -3.14 | -2.11 | -0.89 | Upgrade
|
| EPS (Diluted) | -1.22 | -2.92 | -3.14 | -3.14 | -2.11 | -0.89 | Upgrade
|
| Free Cash Flow | -126.23 | -317.54 | -149.67 | -87.42 | 77.61 | -84.47 | Upgrade
|
| Free Cash Flow Per Share | -1.27 | -3.26 | -1.60 | -0.95 | 0.86 | -0.97 | Upgrade
|
| Gross Margin | -22.11% | -109.36% | -113.13% | -90.89% | -47.82% | 17.99% | Upgrade
|
| Operating Margin | -79.81% | -198.88% | -213.90% | -148.12% | -108.83% | -34.81% | Upgrade
|
| Profit Margin | -67.66% | -192.37% | -208.66% | -123.25% | -107.36% | -30.00% | Upgrade
|
| Free Cash Flow Margin | -70.12% | -214.91% | -106.35% | -37.15% | 44.02% | -32.92% | Upgrade
|
| EBITDA | -139.46 | -283.92 | -290.42 | -333.72 | -169.83 | -67.86 | Upgrade
|
| EBITDA Margin | -77.47% | -192.16% | -206.36% | -141.82% | -96.32% | -26.45% | Upgrade
|
| D&A For EBITDA | 4.22 | 9.93 | 10.6 | 14.81 | 22.05 | 21.45 | Upgrade
|
| EBIT | -143.67 | -293.85 | -301.03 | -348.53 | -191.88 | -89.31 | Upgrade
|
| EBIT Margin | -79.81% | -198.88% | -213.90% | -148.12% | -108.83% | -34.81% | Upgrade
|
| Revenue as Reported | 180.02 | 147.75 | 140.73 | 235.31 | 176.32 | 256.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.